相似文献
1
Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
Blood. 1991 May 15;77(10):2093-5.
2
[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Clin Ter. 2001 May-Jun;152(3):203-6.
3
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
J Clin Oncol. 2003 Feb 15;21(4):583-5. doi: 10.1200/JCO.2003.11.072.
4
Greater curability in advanced Hodgkin's disease?
Cancer J Sci Am. 1999 Sep-Oct;5(5):264-5.
5
Drug selection in the treatment of Hodgkin's disease.
Hematol Oncol. 1983 Jan-Mar;1(1):3-12. doi: 10.1002/hon.2900010103.
6
Hodgkin's lymphoma--the great teacher.
N Engl J Med. 2011 Jul 21;365(3):264-5. doi: 10.1056/NEJMe1104576.
7
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
J Clin Oncol. 2003 Feb 15;21(4):607-14. doi: 10.1200/JCO.2003.12.086.
8
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):947-51.
9
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
Mayo Clin Proc. 1994 Oct;69(10):949-54. doi: 10.1016/s0025-6196(12)61818-7.
10
Conventional salvage therapy for Hodgkin's lymphoma.
Recent Results Cancer Res. 1989;117:225-32. doi: 10.1007/978-3-642-83781-4_24.
引用本文的文献
1
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.
Ann Hematol. 1993 May;66(5):251-6. doi: 10.1007/BF01738475.
Zotero 插件